Webinar On Demand! Register to watch now!

Duration:

1 hour

• Scalable Upstream Process Development of Biotherapeutics

Summary

Speakers

• 

  Moderator:

  Andreia Pedregal
  

  Bioreactor Applications Manager (EMEA),
  Scientific and Laboratory Services
  Pall Biotech
  

  Andreia is the manager of the Pall Bioreactor Application Scientist team in Europe. In her role she supports clients implementing Pall’s bioreactors for development and manufacturing of therapeutics focused on cell and gene, oncolytic, vaccine, monoclonal antibody therapies and others. Andreia holds a Master’s degree in Biotechnology Engineering from the Science and Technology Faculty of Algarve University, Portugal. She has over 10 years of experience in mammalian cell culture, and bioprocess design and optimization, acquired in her previous positions at the Laboratory of Animal Cell Biotechnology and Laboratory of Experimental Medicine at the private research university, ULB, in Brussels, Belgium.
  

• 

  Presenter:

  Divya Goel

  Bioprocess Engineer 
  Celltheon
  

  As the VP of Business Development, Divya Goel oversees platform development and technology licensing for Celltheon. As a bioprocess engineer by training, Divya is not only involved in external facing business opportunities, she also works with the technical staff to evaluate new bioprocessing technologies and develop efficient workflows that can be leveraged by the greater Pharmaceutical Industry. Divya regularly attends scientific conferences to present the Celltheon SMART♦ Technology platform and discuss other advances that Celltheon has made in bioprocessing.

  Divya holds a BS in Biology from Drexel University and a Master’s in Business and Science (MBS) from Keck Graduate Institute in Bioprocess Engineering and Business. Since joining Celltheon, many of the client molecules she has overseen have advanced into late stages of development. Divya is committed to overseeing the application of Celltheon’s novel technologies to develop high titer, high quality products and ensuring seamless tech transfer.
• 

  Speaker:

  Sid Gupta

  Global Product Manager
  Pall Biotech
  

  Sid Gupta is a Global Product Manager at Pall Biotech. He is responsible for lifecycle management and new product development within the Allegro STR family of bioreactors. Sid has 8 years of experience with cell and gene therapy, including positions in Process Development and Product Lifecycle Management at Juno Therapeutics and the Lonza Group. He has co-authored several peer reviewed articles, book chapters, and holds one patent. Sid obtained his graduate and undergraduate degrees in Biomedical Engineering from the Johns Hopkins University and the Indian Institute of Technology, Guwahati, respectively.
  
  

• 

  Moderator:

  David Johnson

  Pall Biotech
  Senior Global Product Manager, Continuous Purification

  David Johnson joined the Pall Life Sciences team in 2002. The first ten years were spent managing the chromatography column laboratory in the UK and then transitioned to the role of Global Product Manager for Chromatography Hardware. Due to this strong experience in chromatography and downstream processing, he currently holds the position of Senior Product Manager for Continuous Purification.

  David Johnson earned his B.Sc. in biological sciences from Liverpool University in England. David has been working in the biopharmaceutical industry for 17 years.